Answers are grounded in this paper and cite their sources.
Analysis reveals geographic disparities in medication adherence for diabetes, suggesting targeted strategies may improve outcomes.
This analysis highlights geographic differences in medication adherence in patients with T2DM. Patients living in high-income areas and areas with higher percentages of White residents had higher odds of adherence to GLP-1 RA medications. As demand for GLP-1 RA medications grow, future work that identifies reasons for disparities in adherence and potential strategies to improve adherence is critical.
No takes yet. Share an insight, caveat, or question.
Gavin et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: